XL309

ISM3091 · Exelixis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XL309, covering 2025-09-05 to 2025-09-05. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors [Phase 1]